Loading...

Margolis Daniel

Title(s)Member, CTSI
SchoolCTSI
Phone(310) 301-6800
vCardDownload vCard
    Other Positions
    Title(s)Health Sciences Associate Clinical Professor, Abdominal Imaging


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Norris JM, Kinnaird A, Margolis DJ, Padhani AR, Walz J, Kasivisvanathan V. Developments in MRI-targeted prostate biopsy. Curr Opin Urol. 2020 Jan; 30(1):1-8. PMID: 31644434.
      View in: PubMed
    2. Lo GC, Margolis DJA. Prostate MRI with PI-RADS v2.1: initial detection and active surveillance. Abdom Radiol (NY). 2019 Dec 03. PMID: 31797025.
      View in: PubMed
    3. Gross MD, Marks LS, Sonn GA, Green DA, Wang GJ, Shoag JE, Cabezon E, Margolis DJ, Robinson BD, Hu JC. Reply by Authors. J Urol. 2019 Dec 02; 101097JU000000000000053402. PMID: 31789578.
      View in: PubMed
    4. Turkbey B, Margolis D. Annual short report of the society of abdominal radiology prostate cancer disease-focused panel. Abdom Radiol (NY). 2019 Dec; 44(12):4000-4001. PMID: 31587097.
      View in: PubMed
    5. Roudenko A, Wilcox Vanden Berg RN, Song C, Prince MR, Paduch DA, Margolis D. Utility of dynamic MRA in the evaluation of male erectile dysfunction. Abdom Radiol (NY). 2019 Nov 29. PMID: 31784778.
      View in: PubMed
    6. Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, Rosenkrantz AB, Rubenstein JN, Rukstalis DB, Taneja SS, Turkbey B. Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer. J Urol. 2019 Oct 23; 101097JU0000000000000617. PMID: 31642740.
      View in: PubMed
    7. Alshak MN, Patel N, Gross MD, Margolis D, Hu JC. Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy. Urology. 2019 Sep 27. PMID: 31568795.
      View in: PubMed
    8. Gross MD, Marks LS, Sonn GA, Green DA, Wang GJ, Shoag JE, Cabezon E, Margolis DJ, Robinson BD, Hu JC. Variation in MRI-Ultrasound Fusion Targeted Biopsy Outcomes in Asian-American Men: A Multi-Center Study. J Urol. 2019 Sep 10; 101097JU0000000000000534. PMID: 31502942.
      View in: PubMed
    9. Goel S, Shoag JE, Gross MD, Al Hussein Al Awamlh B, Robinson B, Khani F, Baltich Nelson B, Margolis DJ, Hu JC. Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2019 Sep 04. PMID: 31492650.
      View in: PubMed
    10. Patel N, Cricco-Lizza E, Kasabwala K, Xu C, Robinson BD, Khani F, Wang Y, Margolis D, Hu JC. Corrigendum to 'The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy' [European Urology Oncology 1 (2018) 263-267]. Eur Urol Oncol. 2019 Aug 01. PMID: 31378664.
      View in: PubMed
    11. Felker ER, Raman SS, Lu DSK, Tuttle M, Margolis DJ, ElKhoury FF, Sayre J, Marks LS. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation. AJR Am J Roentgenol. 2019 Dec; 213(6):1253-1258. PMID: 31361529.
      View in: PubMed
    12. Maas MC, Litjens GJS, Wright AJ, Attenberger UI, Haider MA, Helbich TH, Kiefer B, Macura KJ, Margolis DJA, Padhani AR, Selnæs KM, Villeirs GM, Fütterer JJ, Scheenen TWJ. A Single-Arm, Multicenter Validation Study of Prostate Cancer Localization and Aggressiveness With a Quantitative Multiparametric Magnetic Resonance Imaging Approach. Invest Radiol. 2019 07; 54(7):437-447. PMID: 30946180.
      View in: PubMed
    13. Padhani AR, Barentsz J, Villeirs G, Rosenkrantz AB, Margolis DJ, Turkbey B, Thoeny HC, Cornud F, Haider MA, Macura KJ, Tempany CM, Verma S, Weinreb JC. PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway. Radiology. 2019 Aug; 292(2):464-474. PMID: 31184561.
      View in: PubMed
    14. Coy HJ, Douek ML, Ruchalski K, Kim HJ, Gutierrez A, Patel M, Sai V, Margolis DJA, Kaplan A, Brown M, Goldin J, Raman SS. Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell Carcinoma. Radiology. 2019 Jul; 292(1):103-109. PMID: 31084479.
      View in: PubMed
    15. Felker ER, Raman SS, Shakeri S, Mirak SA, Bajgiran AM, Kwan L, Khoshnoodi P, ElKhoury FF, Margolis DJA, Karow D, Lu DSK, White N, Marks LS. Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate Cancer. AJR Am J Roentgenol. 2019 Aug; 213(2):365-370. PMID: 31039011.
      View in: PubMed
    16. Margolis DJA, Hu JC. Vying for Standardization of Bladder Cancer MRI Interpretation and Reporting: VI-RADS. Radiology. 2019 Jun; 291(3):675-676. PMID: 31013187.
      View in: PubMed
    17. Wibulpolprasert P, Raman SS, Hsu W, Margolis DJA, Asvadi NH, Khoshnoodi P, Moshksar A, Tan N, Ahuja P, Maehara CK, Huang J, Sayre J, Lu DSK, Reiter RE. Detection and Localization of Prostate Cancer at 3-T Multiparametric MRI Using PI-RADS Segmentation. AJR Am J Roentgenol. 2019 Apr 17; W1-W10. PMID: 30995090.
      View in: PubMed
    18. Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019 Sep; 76(3):340-351. PMID: 30898406.
      View in: PubMed
    19. Jafari R, Sheth S, Spincemaille P, Nguyen TD, Prince MR, Wen Y, Guo Y, Deh K, Liu Z, Margolis D, Brittenham GM, Kierans AS, Wang Y. Rapid automated liver quantitative susceptibility mapping. J Magn Reson Imaging. 2019 Sep; 50(3):725-732. PMID: 30637892.
      View in: PubMed
    20. Asvadi NH, Afshari Mirak S, Mohammadian Bajgiran A, Khoshnoodi P, Wibulpolprasert P, Margolis D, Sisk A, Reiter RE, Raman SS. 3T multiparametric MR imaging, PIRADSv2-based detection of index prostate cancer lesions in the transition zone and the peripheral zone using whole mount histopathology as reference standard. Abdom Radiol (NY). 2018 11; 43(11):3117-3124. PMID: 29725743.
      View in: PubMed
    21. Gaur S, Lay N, Harmon SA, Doddakashi S, Mehralivand S, Argun B, Barrett T, Bednarova S, Girometti R, Karaarslan E, Kural AR, Oto A, Purysko AS, Antic T, Magi-Galluzzi C, Saglican Y, Sioletic S, Warren AY, Bittencourt L, Fütterer JJ, Gupta RT, Kabakus I, Law YM, Margolis DJ, Shebel H, Westphalen AC, Wood BJ, Pinto PA, Shih JH, Choyke PL, Summers RM, Turkbey B. Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation. Oncotarget. 2018 Sep 18; 9(73):33804-33817. PMID: 30333911.
      View in: PubMed
    22. Nagarajan MB, Raman SS, Lo P, Lin WC, Khoshnoodi P, Sayre JW, Ramakrishna B, Ahuja P, Huang J, Margolis DJA, Lu DSK, Reiter RE, Goldin JG, Brown MS, Enzmann DR. Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate. Abdom Radiol (NY). 2018 09; 43(9):2487-2496. PMID: 29460041.
      View in: PubMed
    23. Kasabwala K, Patel N, Cricco-Lizza E, Shimpi AA, Weng S, Buchmann RM, Motanagh S, Wu Y, Banerjee S, Khani F, Margolis DJ, Robinson BD, Hu JC. The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy. Eur Urol Oncol. 2019 Mar; 2(2):135-140. PMID: 31017088.
      View in: PubMed
    24. Spilseth B, Margolis DJ, Ghai S, Patel NU, Rosenkrantz AB. Radiologists' preferences regarding content of prostate MRI reports: a survey of the Society of Abdominal Radiology. Abdom Radiol (NY). 2018 07; 43(7):1807-1812. PMID: 29128994.
      View in: PubMed
    25. Patel N, Cricco-Lizza E, Kasabwala K, Xu C, Robinson BD, Khani F, Wang Y, Margolis D, Hu JC. The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy. Eur Urol Oncol. 2018 09; 1(4):263-267. PMID: 31100246.
      View in: PubMed
    26. Gaur S, Harmon S, Gupta RT, Margolis DJ, Lay N, Mehralivand S, Merino MJ, Wood BJ, Pinto PA, Shih JH, Choyke PL, Turkbey B. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI). Acad Radiol. 2019 01; 26(1):5-14. PMID: 29705281.
      View in: PubMed
    27. Vanden Berg RNW, McClure TD, Margolis DJA. A Review of Prostate Biopsy Techniques. Semin Roentgenol. 2018 Jul; 53(3):213-218. PMID: 30031414.
      View in: PubMed
    28. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budäus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018 May 10; 378(19):1767-1777. PMID: 29552975.
      View in: PubMed
    29. Patel N, Halpern JA, Kasabwala K, Cricco-Lizza E, Herman M, Margolis D, Xu C, Robinson BD, Wang Y, McClure T, Hu JC. Multiple Regions of Interest on Multiparametric Magnetic Resonance Imaging are Not Associated with Increased Detection of Clinically Significant Prostate Cancer on Fusion Biopsy. J Urol. 2018 09; 200(3):559-563. PMID: 29518433.
      View in: PubMed
    30. Shao X, Liu D, Martin T, Chanlaw T, Devaskar SU, Janzen C, Murphy AM, Margolis D, Sung K, Wang DJJ. Measuring human placental blood flow with multidelay 3D GRASE pseudocontinuous arterial spin labeling at 3T. J Magn Reson Imaging. 2018 06; 47(6):1667-1676. PMID: 29135072.
      View in: PubMed
    31. Spilseth B, Ghai S, Patel NU, Taneja SS, Margolis DJ, Rosenkrantz AB. A Comparison of Radiologists' and Urologists' Opinions Regarding Prostate MRI Reporting: Results From a Survey of Specialty Societies. AJR Am J Roentgenol. 2018 Jan; 210(1):101-107. PMID: 29064758.
      View in: PubMed
    32. Dinerman BF, Khani F, Golan R, Bernstein AN, Cosiano MF, Margolis DJ, Hu JC. Population-based study of the incidence and survival for intraductal carcinoma of the prostate. Urol Oncol. 2017 12; 35(12):673.e9-673.e14. PMID: 28919182.
      View in: PubMed
    33. Westphalen AC, Margolis DJA, Rosenkrantz AB. The Director of Prostate Imaging: advancing care for prostate cancer patients. Abdom Radiol (NY). 2017 09; 42(9):2358-2362. PMID: 28396916.
      View in: PubMed
    34. Felker ER, Raman SS, Margolis DJ, Lu DSK, Shaheen N, Natarajan S, Sharma D, Huang J, Dorey F, Marks LS. Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary? AJR Am J Roentgenol. 2017 Dec; 209(6):1272-1277. PMID: 28858541.
      View in: PubMed
    35. Nassiri N, Chang E, Lieu P, Priester AM, Margolis DJA, Huang J, Reiter RE, Dorey FJ, Marks LS, Natarajan S. Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy. J Urol. 2018 02; 199(2):453-458. PMID: 28830754.
      View in: PubMed
    36. Chang E, Jones TA, Natarajan S, Sharma D, Simopoulos D, Margolis DJ, Huang J, Dorey FJ, Marks LS. Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer. J Urol. 2018 01; 199(1):98-105. PMID: 28728993.
      View in: PubMed
    37. Margolis DJA. Editorial Comment. J Urol. 2017 09; 198(3):590. PMID: 28627480.
      View in: PubMed
    38. Young JR, Young JA, Margolis DJA, Sauk S, Sayre J, Pantuck AJ, Raman SS. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT. Acad Radiol. 2017 10; 24(10):1226-1232. PMID: 28528853.
      View in: PubMed
    39. Jamshidi N, Margolis DJ, Raman S, Huang J, Reiter RE, Kuo MD. Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma. Radiology. 2017 07; 284(1):109-119. PMID: 28453432.
      View in: PubMed
    40. Natarajan S, Jones TA, Priester AM, Geoghegan R, Lieu P, Delfin M, Felker E, Margolis DJA, Sisk A, Pantuck A, Grundfest W, Marks LS. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance. J Urol. 2017 10; 198(4):839-847. PMID: 28396184.
      View in: PubMed
    41. Ellis-Caleo T, Hegde JV, Batth S, Mesko S, Reiter R, Margolis D, Kamrava M. Imaging and Pathology Correlations for Different Risk Stratification Models for Intermediate-risk Prostate Cancer. Anticancer Res. 2017 03; 37(3):1237-1242. PMID: 28314287.
      View in: PubMed
    42. McClure TD, Margolis DJ, Hu JC. Partial gland ablation in the management of prostate cancer: a review. Curr Opin Urol. 2017 03; 27(2):156-160. PMID: 28033149.
      View in: PubMed
    43. Feng Z, Min X, Margolis DJ, Duan C, Chen Y, Sah VK, Chaudhary N, Li B, Ke Z, Zhang P, Wang L. Evaluation of different mathematical models and different b-value ranges of diffusion-weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm2. PLoS One. 2017; 12(2):e0172127. PMID: 28199367.
      View in: PubMed
    44. Verma S, Rosenkrantz AB, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsy. Abdom Radiol (NY). 2017 Feb; 42(2):346-349. PMID: 27670878.
      View in: PubMed
    45. Kim YK, Lin WC, Sung K, Raman SS, Margolis D, Lim Y, Gu S, Lu D. Reducing Artifacts during Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: Dilution Method versus Reduced Injection Rate. Radiology. 2017 05; 283(2):429-437. PMID: 27977329.
      View in: PubMed
    46. Tan N, Lin WC, Khoshnoodi P, Asvadi NH, Yoshida J, Margolis DJ, Lu DS, Wu H, Sung KH, Lu DY, Huang J, Raman SS. In-Bore 3-T MR-guided Transrectal Targeted Prostate Biopsy: Prostate Imaging Reporting and Data System Version 2-based Diagnostic Performance for Detection of Prostate Cancer. Radiology. 2017 04; 283(1):130-139. PMID: 27861110.
      View in: PubMed
    47. Young JR, Young JA, Margolis DJ, Sauk S, Pantuck AJ, Sayre J, Raman SS. Clear cell renal cell carcinoma: identifying the gain of chromosome 20 on multiphasic MDCT. Abdom Radiol (NY). 2016 11; 41(11):2175-2181. PMID: 27315079.
      View in: PubMed
    48. Nassiri N, Margolis DJ, Natarajan S, Sharma DS, Huang J, Dorey FJ, Marks LS. Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer. J Urol. 2017 03; 197(3 Pt 1):632-639. PMID: 27639713.
      View in: PubMed
    49. Dumesic DA, Akopians AL, Madrigal VK, Ramirez E, Margolis DJ, Sarma MK, Thomas AM, Grogan TR, Haykal R, Schooler TA, Okeya BL, Abbott DH, Chazenbalk GD. Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women. J Clin Endocrinol Metab. 2016 11; 101(11):4178-4188. PMID: 27571186.
      View in: PubMed
    50. Brunsing RL, Schenker-Ahmed NM, White NS, Parsons JK, Kane C, Kuperman J, Bartsch H, Kader AK, Rakow-Penner R, Seibert TM, Margolis D, Raman SS, McDonald CR, Farid N, Kesari S, Hansel D, Shabaik A, Dale AM, Karow DS. Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI. J Magn Reson Imaging. 2017 02; 45(2):323-336. PMID: 27527500.
      View in: PubMed
    51. Priester A, Natarajan S, Khoshnoodi P, Margolis DJ, Raman SS, Reiter RE, Huang J, Grundfest W, Marks LS. Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology. J Urol. 2017 02; 197(2):320-326. PMID: 27484386.
      View in: PubMed
    52. McCammack KC, Raman SS, Margolis DJ. Imaging of local recurrence in prostate cancer. Future Oncol. 2016 Nov; 12(21):2401-2415. PMID: 27306275.
      View in: PubMed
    53. Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. J Urol. 2016 12; 196(6):1613-1618. PMID: 27320841.
      View in: PubMed
    54. Margolis DJ. MR-TRUS Fusion Biopsy. Top Magn Reson Imaging. 2016 Jun; 25(3):125-31. PMID: 27187163.
      View in: PubMed
    55. Rosenkrantz AB, Margolis DJ. Commentary regarding the inter-reader reproducibility of PI-RADS version 2. Abdom Radiol (NY). 2016 05; 41(5):907-9. PMID: 27138435.
      View in: PubMed
    56. Felker ER, Lee-Felker SA, Feller J, Margolis DJ, Lu DS, Princenthal R, May S, Cohen M, Huang J, Yoshida J, Greenwood B, Kim HJ, Raman SS. In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer. Abdom Radiol (NY). 2016 05; 41(5):954-62. PMID: 27118268.
      View in: PubMed
    57. Margolis DJ, Westphalen AC, Haider MA. Why we need a vendor neutral specification for delineating prostate cancer with mpMRI. Abdom Radiol (NY). 2016 05; 41(5):801-2. PMID: 27108130.
      View in: PubMed
    58. McCammack KC, Schenker-Ahmed NM, White NS, Best SR, Marks RM, Heimbigner J, Kane CJ, Parsons JK, Kuperman JM, Bartsch H, Desikan RS, Rakow-Penner RA, Liss MA, Margolis DJ, Raman SS, Shabaik A, Dale AM, Karow DS. Restriction spectrum imaging improves MRI-based prostate cancer detection. Abdom Radiol (NY). 2016 05; 41(5):946-53. PMID: 26910114.
      View in: PubMed
    59. Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Shtern F, Padhani AR, Tempany CM, Thoeny HC, Verma S, Weinreb JC. Reply to Erik Rud and Eduard Baco's Letter to the Editor re: Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40. Eur Urol. 2016 11; 70(5):e137-e138. PMID: 27130148.
      View in: PubMed
    60. Rosenkrantz AB, Ginocchio LA, Cornfeld D, Froemming AT, Gupta RT, Turkbey B, Westphalen AC, Babb JS, Margolis DJ. Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists. Radiology. 2016 Sep; 280(3):793-804. PMID: 27035179.
      View in: PubMed
    61. Felker ER, Margolis DJ, Nassiri N, Marks LS. Prostate cancer risk stratification with magnetic resonance imaging. Urol Oncol. 2016 07; 34(7):311-9. PMID: 27040381.
      View in: PubMed
    62. Gulati M, Dermendjian H, Gómez AM, Tan N, Margolis DJ, Lu DS, Gritsch HA, Raman SS. 3.0Tesla magnetic resonance angiography (MRA) for comprehensive renal evaluation of living renal donors: pilot study with computerized tomography angiography (CTA) comparison. Clin Imaging. 2016 May-Jun; 40(3):370-7. PMID: 27133670.
      View in: PubMed
    63. Filson CP, Natarajan S, Margolis DJ, Huang J, Lieu P, Dorey FJ, Reiter RE, Marks LS. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies. Cancer. 2016 Mar 15; 122(6):884-92. PMID: 26749141.
      View in: PubMed
    64. Natarajan S, Raman S, Priester AM, Garritano J, Margolis DJ, Lieu P, Macairan ML, Huang J, Grundfest W, Marks LS. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial. J Urol. 2016 07; 196(1):68-75. PMID: 26748164.
      View in: PubMed
    65. Felker ER, Wu J, Natarajan S, Margolis DJ, Raman SS, Huang J, Dorey F, Marks LS. Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value. J Urol. 2016 May; 195(5):1421-1427. PMID: 26674305.
      View in: PubMed
    66. Laviana AA, Ilg AM, Veruttipong D, Tan HJ, Burke MA, Niedzwiecki DR, Kupelian PA, King CR, Steinberg ML, Kundavaram CR, Kamrava M, Kaplan AL, Moriarity AK, Hsu W, Margolis DJ, Hu JC, Saigal CS. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer. Cancer. 2016 Feb 01; 122(3):447-55. PMID: 26524087.
      View in: PubMed
    67. Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM, Thoeny HC, Verma S. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol. 2016 Jan; 69(1):16-40. PMID: 26427566.
      View in: PubMed
    68. Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol. 2016 Jan; 69(1):41-9. PMID: 26361169.
      View in: PubMed
    69. Brown AM, Elbuluk O, Mertan F, Sankineni S, Margolis DJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B. Recent advances in image-guided targeted prostate biopsy. Abdom Imaging. 2015 Aug; 40(6):1788-99. PMID: 25596716.
      View in: PubMed
    70. Schwope RB, May LA, Reiter MJ, Lisanti CJ, Margolis DJ. Gadoxetic acid: pearls and pitfalls. Abdom Imaging. 2015 Aug; 40(6):2012-29. PMID: 25613332.
      View in: PubMed
    71. Rakow-Penner RA, White NS, Margolis DJA, Parsons JK, Schenker-Ahmed N, Kuperman JM, Bartsch H, Choi HW, Bradley WG, Shabaik A, Huang J, Liss MA, Marks L, Kane CJ, Reiter RE, Raman SS, Karow DS, Dale AM. Prostate diffusion imaging with distortion correction. Magn Reson Imaging. 2015 Nov; 33(9):1178-1181. PMID: 26220859.
      View in: PubMed
    72. Nassiri N, Natarajan S, Margolis DJ, Marks LS. Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology. Urology. 2015 Sep; 86(3):432-8. PMID: 26166671.
      View in: PubMed
    73. Tan N, Margolis DJ, Lu DY, King KG, Huang J, Reiter RE, Raman SS. Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology. AJR Am J Roentgenol. 2015 Jul; 205(1):W87-92. PMID: 26102423.
      View in: PubMed
    74. Kamrava M, Kishan AU, Margolis DJ, Huang J, Dorey F, Lieu P, Kupelian PA, Marks LS. Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):411-6. PMID: 26059510.
      View in: PubMed
    75. Tan N, Charoensak A, Ajwichai K, Gritsch HA, Danovitch G, Schulam P, Lu DS, Margolis DJ, Raman SS. Prevalence of incidental findings on abdominal computed tomography angiograms on prospective renal donors. Transplantation. 2015 Jun; 99(6):1203-7. PMID: 25651306.
      View in: PubMed
    76. Liss MA, White NS, Parsons JK, Schenker-Ahmed NM, Rakow-Penner R, Kuperman JM, Bartsch H, Choi HW, Mattrey RF, Bradley WG, Shabaik A, Huang J, Margolis DJ, Raman SS, Marks LS, Kane CJ, Reiter RE, Dale AM, Karow DS. MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens. Front Oncol. 2015; 5:30. PMID: 25741473.
      View in: PubMed
    77. Rastegar N, Matteoni-Athayde LG, Eng J, Takahashi N, Tamm EP, Mortele KJ, Syngal S, Margolis D, Lennon AM, Wolfgang CL, Fishman EK, Hruban RH, Goggins M, Canto MI, Kamel IR. Incremental value of secretin-enhanced magnetic resonance cholangiopancreatography in detecting ductal communication in a population with high prevalence of small pancreatic cysts. Eur J Radiol. 2015 Apr; 84(4):575-80. PMID: 25619503.
      View in: PubMed
    78. Li L, Margolis DJ, Deng M, Cai J, Yuan L, Feng Z, Min X, Hu Z, Hu D, Liu J, Wang L. Correlation of gleason scores with magnetic resonance diffusion tensor imaging in peripheral zone prostate cancer. J Magn Reson Imaging. 2015 Aug; 42(2):460-7. PMID: 25469909.
      View in: PubMed
    79. Margolis DJ. Multiparametric MRI for localized prostate cancer: lesion detection and staging. Biomed Res Int. 2014; 2014:684127. PMID: 25525600.
      View in: PubMed
    80. Lee-Felker SA, Felker ER, Tan N, Margolis DJ, Young JR, Sayre J, Raman SS. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. AJR Am J Roentgenol. 2014 Nov; 203(5):W516-24. PMID: 25341166.
      View in: PubMed
    81. Le JD, Tan N, Shkolyar E, Lu DY, Kwan L, Marks LS, Huang J, Margolis DJ, Raman SS, Reiter RE. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol. 2015 Mar; 67(3):569-76. PMID: 25257029.
      View in: PubMed
    82. Srinivasan S, Wu HH, Sung K, Margolis DJ, Ennis DB. Fast 3D T2 -weighted imaging using variable flip angle transition into driven equilibrium (3D T2 -TIDE) balanced SSFP for prostate imaging at 3T. Magn Reson Med. 2015 Aug; 74(2):442-51. PMID: 25195659.
      View in: PubMed
    83. Chung MP, Margolis D, Mesko S, Wang J, Kupelian P, Kamrava M. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer. J Med Imaging Radiat Oncol. 2014 Oct; 58(5):588-94. PMID: 25196228.
      View in: PubMed
    84. White NS, McDonald C, McDonald CR, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Kaine CJ, Carter BS, Bradley WG, Dale AM. Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Res. 2014 Sep 01; 74(17):4638-52. PMID: 25183788.
      View in: PubMed
    85. Priester A, Natarajan S, Le JD, Garritano J, Radosavcev B, Grundfest W, Margolis DJ, Marks LS, Huang J. A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds. Am J Clin Exp Urol. 2014; 2(2):127-35. PMID: 25374914.
      View in: PubMed
    86. Sonn GA, Filson CP, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer. Urol Oncol. 2014 Oct; 32(7):952-7. PMID: 25027689.
      View in: PubMed
    87. Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Young JA, Hsu M, Raman SS. Clear cell renal cell carcinoma: multiphasic MDCT enhancement can predict the loss of chromosome 8p. Abdom Imaging. 2014 Jun; 39(3):543-9. PMID: 24573763.
      View in: PubMed
    88. Le JD, Stephenson S, Brugger M, Lu DY, Lieu P, Sonn GA, Natarajan S, Dorey FJ, Huang J, Margolis DJ, Reiter RE, Marks LS. Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology. J Urol. 2014 Nov; 192(5):1367-73. PMID: 24793118.
      View in: PubMed
    89. Anderson ES, Margolis DJ, Mesko S, Banerjee R, Wang PC, Demanes DJ, Kupelian P, Kamrava M. Multiparametric MRI identifies and stratifies prostate cancer lesions: implications for targeting intraprostatic targets. Brachytherapy. 2014 May-Jun; 13(3):292-8. PMID: 24709516.
      View in: PubMed
    90. Hu JC, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Sonn G, Dorey FJ, Marks LS. Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? J Urol. 2014 Aug; 192(2):385-90. PMID: 24512956.
      View in: PubMed
    91. Chamie K, Sonn GA, Finley DS, Tan N, Margolis DJ, Raman SS, Natarajan S, Huang J, Reiter RE. The role of magnetic resonance imaging in delineating clinically significant prostate cancer. Urology. 2014 Feb; 83(2):369-75. PMID: 24468511.
      View in: PubMed
    92. Sonn GA, Margolis DJ, Marks LS. Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy. Urol Oncol. 2014 Aug; 32(6):903-11. PMID: 24239473.
      View in: PubMed
    93. Thomas MA, Nagarajan R, Huda A, Margolis D, Sarma MK, Sheng K, Reiter RE, Raman SS. Multidimensional MR spectroscopic imaging of prostate cancer in vivo. NMR Biomed. 2014 Jan; 27(1):53-66. PMID: 23904127.
      View in: PubMed
    94. Nagarajan R, Margolis DJ, Raman SS, Ouellette D, Sarma MK, Reiter RE, Thomas MA. MR Spectroscopic Imaging of Peripheral Zone in Prostate Cancer Using a 3T MRI Scanner: Endorectal versus External Phased Array Coils. Magn Reson Insights. 2013; 6:51-8. PMID: 25114544.
      View in: PubMed
    95. Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz L, Margolis DJ, Marks LS, Melamed J, Oto A, Palmer SL, Pinto P, Puech P, Punwani S, Rosenkrantz AB, Schoots IG, Simon R, Taneja SS, Turkbey B, Ukimura O, van der Meulen J, Villers A, Watanabe Y. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol. 2013 Oct; 64(4):544-52. PMID: 23537686.
      View in: PubMed
    96. Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol. 2014 Apr; 65(4):809-15. PMID: 23523537.
      View in: PubMed
    97. Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 2013 May; 267(2):444-53. PMID: 23382290.
      View in: PubMed
    98. Sonn GA, Natarajan S, Margolis DJ, MacAiran M, Lieu P, Huang J, Dorey FJ, Marks LS. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol. 2013 Jan; 189(1):86-91. PMID: 23158413.
      View in: PubMed
    99. Kaplan AL, Margolis DJ, Said J, Chin AI. Primary carcinoid tumor of urinary bladder discovered on pelvic magnetic resonance imaging. Urology. 2012 Nov; 80(5):e55-7. PMID: 23107414.
      View in: PubMed
    100. Tan N, Margolis DJ, McClure TD, Thomas A, Finley DS, Reiter RE, Huang J, Raman SS. Radical prostatectomy: value of prostate MRI in surgical planning. Abdom Imaging. 2012 Aug; 37(4):664-74. PMID: 21993567.
      View in: PubMed
    101. Finley DS, Ellingson BM, Natarajan S, Zaw TM, Raman SS, Schulam P, Reiter RE, Margolis D. Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers. Urology. 2012 Jul; 80(1):219-23. PMID: 22748877.
      View in: PubMed
    102. Nagarajan R, Margolis D, Raman S, Sarma MK, Sheng K, King CR, Verma G, Sayre J, Reiter RE, Thomas MA. MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores. J Magn Reson Imaging. 2012 Sep; 36(3):697-703. PMID: 22581787.
      View in: PubMed
    103. Furuyama JK, Wilson NE, Burns BL, Nagarajan R, Margolis DJ, Thomas MA. Application of compressed sensing to multidimensional spectroscopic imaging in human prostate. Magn Reson Med. 2012 Jun; 67(6):1499-505. PMID: 22505247.
      View in: PubMed
    104. Boortz HE, Margolis DJ, Ragavendra N, Patel MK, Kadell BM. Migration of intrauterine devices: radiologic findings and implications for patient care. Radiographics. 2012 Mar-Apr; 32(2):335-52. PMID: 22411936.
      View in: PubMed
    105. McClure TD, Margolis DJ, Reiter RE, Sayre JW, Thomas MA, Nagarajan R, Gulati M, Raman SS. Use of MR imaging to determine preservation of the neurovascular bundles at robotic-assisted laparoscopic prostatectomy. Radiology. 2012 Mar; 262(3):874-83. PMID: 22274837.
      View in: PubMed
    106. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012 Apr; 142(4):796-804; quiz e14-5. PMID: 22245846.
      View in: PubMed
    107. Nagarajan R, Margolis D, Raman S, Sheng K, King C, Reiter R, Thomas MA. Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer. Adv Urol. 2012; 2012:374805. PMID: 22216026.
      View in: PubMed
    108. Sauk SC, Hsu MS, Margolis DJ, Lu DS, Rao NP, Belldegrun AS, Pantuck AJ, Raman SS. Clear cell renal cell carcinoma: multiphasic multidetector CT imaging features help predict genetic karyotypes. Radiology. 2011 Dec; 261(3):854-62. PMID: 22025734.
      View in: PubMed
    109. Finley DS, Margolis D, Raman SS, Ellingson BM, Natarajan S, Tan N, Huang J, Reiter RE. Fine-tuning robot-assisted radical prostatectomy planning with MRI. Urol Oncol. 2013 Aug; 31(6):766-75. PMID: 21906964.
      View in: PubMed
    110. Yu NC, Margolis D, Hsu M, Raman SS, Lu DS. Detection and grading of esophageal varices on liver CT: comparison of standard and thin-section multiplanar reconstructions in diagnostic accuracy. AJR Am J Roentgenol. 2011 Sep; 197(3):643-9. PMID: 21862806.
      View in: PubMed
    111. Nagarajan R, Margolis D, McClure T, Raman S, Thomas MA. Role of endorectal magnetic resonance spectroscopic imaging in two different Gleason scores in prostate cancer. Med Princ Pract. 2011; 20(5):444-8. PMID: 21757934.
      View in: PubMed
    112. Natarajan S, Marks LS, Margolis DJ, Huang J, Macairan ML, Lieu P, Fenster A. Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol. 2011 May-Jun; 29(3):334-42. PMID: 21555104.
      View in: PubMed
    113. Schwope RB, Margolis DJ, Raman SS, Kadell BM. Portal vein aneurysms: a case series with literature review. J Radiol Case Rep. 2010; 4(6):28-38. PMID: 22470738.
      View in: PubMed
    114. Tse G, Chow DS, Hsu M, Margolis D, Raman SS. Multidetector computed tomographic features of oncocytic papillary renal cell carcinoma, a new subtype. J Comput Assist Tomogr. 2010 May-Jun; 34(3):380-4. PMID: 20498540.
      View in: PubMed
    115. Nagarajan R, Gomez AM, Raman SS, Margolis DJ, McClure T, Thomas MA. Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients. NMR Biomed. 2010 Apr; 23(3):257-61. PMID: 19795373.
      View in: PubMed
    116. Prasad MN, Brown MS, Ni C, Margolis DJ, Douek M, Raman S, Lu D, Goldin J. Three-dimensional mapping of gallbladder wall thickness on computed tomography using Laplace's equation. Acad Radiol. 2008 Aug; 15(8):1075-81. PMID: 18620128.
      View in: PubMed
    117. Thomas MA, Lange T, Velan SS, Nagarajan R, Raman S, Gomez A, Margolis D, Swart S, Raylman RR, Schulte RF, Boesiger P. Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo. MAGMA. 2008 Nov; 21(6):443-58. PMID: 18633659.
      View in: PubMed
    118. Tabibian JH, Lassman CR, Margolis DJ, Landaverde C, Busuttil RW, Durazo FA. Intraductal oncocytic papillary neoplasm of the liver: case and review of a rare variant. Ann Hepatol. 2008 Apr-Jun; 7(2):168-73. PMID: 18626437.
      View in: PubMed
    119. Oaks J, Margolis DJ. Spindle cell lipoma of the mediastinum: a differential consideration for liposarcoma. J Thorac Imaging. 2007 Nov; 22(4):355-7. PMID: 18043393.
      View in: PubMed
    120. Margolis DJ, Hoffman JM, Herfkens RJ, Jeffrey RB, Quon A, Gambhir SS. Molecular imaging techniques in body imaging. Radiology. 2007 Nov; 245(2):333-56. PMID: 17940297.
      View in: PubMed
    121. Ghanouni P, Kurian AW, Margolis D, Hartman AR, Mills MA, Plevritis SK, Ford JM, Daniel BL. Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage. Breast J. 2007 May-Jun; 13(3):281-6. PMID: 17461903.
      View in: PubMed
    122. Po J, Margolis DJ, Cunningham CH, Herfkens RJ, Ikeda DM, Daniel BL. Water-selective spectral-spatial contrast-enhanced breast MRI for cancer detection in patients with extracapsular and injected free silicone. Magn Reson Imaging. 2006 Dec; 24(10):1363-7. PMID: 17145408.
      View in: PubMed
    123. Shi R, Schraedley-Desmond P, Napel S, Olcott EW, Jeffrey RB, Yee J, Zalis ME, Margolis D, Paik DS, Sherbondy AJ, Sundaram P, Beaulieu CF. CT colonography: influence of 3D viewing and polyp candidate features on interpretation with computer-aided detection. Radiology. 2006 Jun; 239(3):768-76. PMID: 16714460.
      View in: PubMed
    124. Kim DH, Margolis D, Xing L, Daniel B, Spielman D. In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3 T. Magn Reson Med. 2005 May; 53(5):1177-82. PMID: 15844143.
      View in: PubMed
    125. Margolis DJ, Bammer R, Chow LC. Parallel imaging of the abdomen. Top Magn Reson Imaging. 2004 Jun; 15(3):197-206. PMID: 15480001.
      View in: PubMed
    126. Filmont JE, Yap CS, Ko F, Vranjesevic D, Quon A, Margolis DJ, Safaei A, Emmanouilides C, Silverman DH, Phelps ME, Czernin J. Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease. Mol Imaging Biol. 2004 Jan-Feb; 6(1):47-54. PMID: 15018828.
      View in: PubMed
    127. Filmont JE, Vranjesevic D, Quon A, Margolis DJ, Ko F, Safaei A, Emmanouilides C, Silverman DH, Rao J, Valk PE, Phelps ME, Czernin J. Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients. Mol Imaging Biol. 2003 Jul-Aug; 5(4):232-9. PMID: 14499138.
      View in: PubMed